Before a nurse practitioner sees a single patient in a new state, someone on your team has to answer a deceptively simple question: does this state require us to file anything, or get board approval, before this NP can legally practice here? The answer changes at the state line, and getting it wrong is one of the most common ways a multi-state expansion stalls or creates audit exposure.

In many states, nothing needs to be filed. In others, the NP cannot legally practice until a board grants approval, which can take weeks. And in a large group of states, the filing obligation is not triggered by practice at all. It is triggered by prescribing, and specifically by controlled substances.

This guide breaks down, state by state, whether an NP must file paperwork or obtain board approval before practicing, who the filing involves, and what triggers the requirement.

This article is for educational purposes only and does not constitute legal advice. Healthcare organizations should consult qualified counsel when making regulatory decisions.

Quick Answer: NP Board Filing Requirements by State

As of 2026, most states do not require an NP to file a collaborative agreement or obtain board approval simply to practice, because roughly 30 states plus Washington, D.C. grant some form of full practice authority. A smaller group of states require the NP to obtain board approval before practicing (for example, Alabama, Louisiana, Mississippi, and North Carolina). A separate and larger group requires a filing only when the NP prescribes, especially controlled substances (for example, Georgia, Illinois, Indiana, Missouri, Nevada, Oklahoma, Pennsylvania, Tennessee, Texas, and West Virginia). Because these rules change frequently, always confirm the current requirement with the relevant state board before deploying a provider.

The Four Filing Patterns Every Compliance Team Should Know

Across all 50 states, NP board filing requirements fall into four practical patterns. Understanding the pattern matters more than memorizing any single rule, because it tells your team when a provider can start seeing patients and what has to happen first.

1. Board approval required before practice

The NP cannot legally see patients until the board reviews the filing and issues approval. This is the highest-friction pattern because it introduces a waiting period that can run from days to two months, and it is the pattern most likely to derail a launch timeline if it is discovered late.

2. Filing or notice required, but practice is permitted

The NP (or the physician) must file something with the board, but the provider can begin practicing on or shortly after filing without waiting for approval. The obligation is real and enforceable, but it does not gate the start date.

3. Filing triggered by prescribing or controlled substances

Nothing needs to be filed to practice, but the moment the NP intends to prescribe, and especially to prescribe controlled substances, a filing requirement attaches. This is the pattern teams miss most often, because the NP appears cleared to work when the prescribing obligation has not yet been satisfied.

4. No filing required to practice

Full practice authority states where an NP does not file a collaborative agreement or obtain approval to practice. Some of these states still require a one-time transition filing or a prescribing-related step, which is covered below.

States That Require Board Approval Before an NP Can Practice

These are the states where a filing gates the provider’s start date. Your operational plan has to build in the review period, because the NP cannot legally see patients until approval is issued.

• Alabama: The NP applies online and files the standard protocol, and the collaborating physician files a Collaboration Commencement Form. Temporary approval to practice is typically issued within days once requirements are verified, but full approval generally takes 45 to 60 days because the board reviews applications monthly. If the collaborative arrangement changes, it must be re-submitted.
• Louisiana: The collaborating physician must be approved by the Louisiana State Board of Nursing before the NP begins clinical practice, and the NP files an Attestation of Prescriptive Authority as notification of the relationship. Any change, including deletion of a collaborating physician, must be reported within 30 days.
• Mississippi: An NP may not practice without a board-approved collaborative or consultative relationship and a board-approved protocol. Filing is required at license application, at renewal, and on any change to the agreement. Collaborations where the NP practices more than 75 miles from the physician require the physician to submit a letter through the state gateway.
• North Carolina: The NP cannot practice until the Board of Nursing issues an approval-to-practice notification, which follows approval by both the Board of Nursing and the Medical Board. Adding or changing a supervising physician, or changing scope, requires re-submission and a new approval-to-practice notification before the NP can resume seeing patients.
• Washington: For NPs completing a supervised transition experience, a written notification with the preceptor agreement must be submitted 30 days before practice begins, and the board issues an interim permit for the supervised period. This is a front-loaded timeline that has to be planned around.

States Where Filing Is Required But Practice Is Permitted

In these states, your obligation is real, but it does not delay the start date. The provider can begin practicing on or shortly after filing.

• Colorado: Requires collaboration or mentorship documentation before the NP accrues the transition hours needed for full prescriptive authority, but no approval is required to begin practicing.
• Florida: Requires the physician to submit notice to the board within 30 days of entering the collaboration.
• Kentucky: Requires the NP to notify the Board of Nursing of the collaborative agreement’s existence through the Nurse Portal, and only notification is required.
• Ohio: Requires the NP to submit the collaborating physician’s name and business address within 30 days of first practicing.
• South Carolina: Requires notice to the board of a change in physician or practice setting within 15 business days, unless the filing is part of a prescriptive authority application.

States Where the Filing Is Triggered by Prescribing

This is the pattern teams miss most often. In these states, an NP can be cleared to practice while a separate, unmet obligation attaches the moment they prescribe, and controlled substances usually carry the strictest requirements.

• Arkansas: A Collaborative Practice Agreement and Quality Assurance Plan must be on file with the Board of Nursing before the NP can prescribe. The NP cannot prescribe until the CPA is approved.
• Georgia: A nurse protocol agreement is required only if the NP will write prescriptions. Controlled substances in Schedules III through V cannot be written until the board has reviewed the protocol and the NP has obtained a DEA number.
• Illinois: The collaborating physician must file a notice of delegation of prescriptive authority with the Department and the Prescription Monitoring Program. To prescribe controlled substances, the NP also needs an Illinois Controlled Substance license.
• Indiana: The written collaborative agreement is part of the prescriptive authority application and must be re-filed at every prescriptive authority renewal. It is not valid until prescriptive authority is granted.
• Missouri: For controlled substance prescriptive authority, the NP submits an attestation of collaboration and the physician submits notice of the collaboration within 30 days.
• Nevada: The Collaboration Agreement is submitted to the Board of Nursing as part of the Schedule II application, and the physician notifies the Board of Medicine (or Osteopathic Medicine). NPs with fewer than two years or 2,000 hours of APRN practice must submit a protocol for Schedule II prescribing.
• Oklahoma: The Collaboration Agreement is filed with the prescriptive authority application and at each renewal, by both the NP and the physician, and the physician also files with the Board of Medicine. Changes are effective on filing.
• Pennsylvania: Board approval is not required to practice, but prescribing is gated. The NP must submit a Prescriptive Authority application for each collaborating physician, and an approval is granted per application before the NP can prescribe under that collaboration.
• Tennessee: For prescribing, the NP files a notice naming the physician and the permitted drug schedules, and controlled substance relationships are documented in the Controlled Substance Monitoring Database by both the NP and the physician.
• Texas: The delegating physician registers the delegation of prescriptive authority with the board within 30 days. An out-of-state NP address requires the Out of State Delegation Form.
• West Virginia: The collaborative agreement is filed as part of the prescriptive authority application, and the NP updates the Nurse Portal when adding or removing a collaboration or changing prescriptive authority status.

The operational takeaway: “cleared to practice” and “cleared to prescribe” are two different states of readiness. A provider who is authorized to see patients may still be days or weeks away from being able to write prescriptions, and controlled substances often add a DEA registration, a state controlled substance license, or a separate protocol on top of the base filing

Transition-to-Independence Filings in Full Practice Authority States

Several full practice authority states do not require an ongoing collaborative agreement, but they do require a one-time filing while the NP completes a transition period. These are easy to overlook because the state is often described simply as “full practice authority.”

• California: Does not require the board to approve standardized procedures, and there is no collaboration filing, but the state operates a 103-to-104 transition-to-practice pathway.
• Maine: Requires the NP to register a supervising relationship with the board as part of the initial authority to practice.
• Maryland: requires the mentor’s name and license number on the initial license application.
• Minnesota: requires the NP to submit an attestation once the collaborative practice experience is complete. Nebraska requires an attestation of supervision when the supervisor is an NP.
• South Dakota: requires a collaborative agreement to be filed with the licensure application if the NP cannot verify 1,040 hours of licensed practice.

A Practical Framework for Tracking Filing Requirements at Scale

For a single provider in a single state, this is a checklist. For an organization deploying dozens of NPs across many states, it is a system. Here is a framework that holds up as you scale.

1. Separate “practice readiness” from “prescribing readiness”

Track them as two distinct gates for every provider in every state. A provider is not fully deployed until both are cleared, and controlled substances may be a third gate.

2. Identify the gating states first

Before committing to a launch date in a new state, confirm whether it is an approval-required state (Pattern 1). Those states dictate your timeline, so they belong at the front of your planning, not the end.

3. Assign each filing an owner and a system of record

Board filings frequently involve the physician, not just the NP, and some require action by both. A filing with no named owner is a filing that does not happen.

4. Track triggers, not just states

Build your tracker around events (new provider, new state, new collaborating physician, new prescriptive authority, controlled substance schedule) rather than a static per-state list. Most filing obligations attach to a change, and many attach to prescribing rather than to practice.

5. Record the recurring obligations

Several states require re-filing at renewal (Indiana, Oklahoma) or on any change to the agreement (Alabama, Georgia, Louisiana, Mississippi, North Carolina, South Carolina). Renewal-linked filings are a common source of lapses because the original filing felt like a one-time task.

6. Keep the documentation audit-ready

Maintain the filed documents, approval notifications, and change history in a form you can produce on request. Audits, board inquiries, and payer reviews are not about your intentions — they’re about whether you can prove compliance with documentation.

Where Zivian Fits

Zivian Health is compliance infrastructure built specifically for healthcare organizations deploying and scaling NP and PA workforces across states. The filing patterns in this guide are exactly the kind of complexity Zivian is designed to remove.

Instead of tracking approval-required states, prescribing triggers, and renewal deadlines in spreadsheets and email threads, teams use Zivian to hold 50-state regulatory intelligence for NP and PA requirements in one place, manage collaboration agreements and board filing requirements, monitor licensing and credentialing, route and document chart review, and produce exportable audit trails when a board, payer, or auditor asks for proof. For organizations that also need to source qualified collaborating physicians in gating states, Zivian’s physician marketplace connects teams with vetted physicians for collaboration, medical directorship, and PC ownership.

The result is that “can this NP practice, and prescribe, in this state yet?” becomes a question your system answers, rather than a question that lives in one coordinator’s head.

See how Zivian helps healthcare organizations manage NP/PA collaboration and board filing requirements across states.

Ready to Replace Spreadsheets with Scalable NP and PA Compliance Infrastructure?

Connect with Zivian today about building audit-ready compliance infrastructure for your NP and PA workforce, so board filing requirements, prescribing triggers, and renewal deadlines are tracked in one platform across every state you operate in.